A pilot study of toceranib/vinblastine therapy for canine transitional cell carcinoma

BACKGROUND: Effective therapies for transitional cell carcinoma (TCC) are limited, with objective response rates to most chemotherapeutic regimens below 20%. The purpose of this study was to investigate the biologic activity of combined toceranib phosphate and vinblastine chemotherapy for treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Rippy, Sarah B., Gardner, Heather L., Nguyen, Sandra M., Warry, Emma E., Portela, Roberta A., Drost, William Tod, Hostnik, Eric T., Green, Eric M., Chew, Dennis J., Peng, Juan, London, Cheryl A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5114733/
https://www.ncbi.nlm.nih.gov/pubmed/27855679
http://dx.doi.org/10.1186/s12917-016-0882-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5114733/
https://www.ncbi.nlm.nih.gov/pubmed/27855679
http://dx.doi.org/10.1186/s12917-016-0882-6

Ejemplares similares